R-Spondin Potentiates Wnt/β-Catenin Signaling through Orphan Receptors LGR4 and LGR5

• Heinz Ruffner ,

  * E-mail: heinz.ruffner@novartis.com (HR); feng.cong@novartis.com (FC)

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Joëlle Sprunger,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Olga Charlat,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Juliet Leighton-Davies,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Bianka Grosshans,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Adrian Salathe,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Svenja Zietzling,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Valérie Beck,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Maxime Therier,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Andrea Isken,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Yang Xie,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Yue Zhang,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Huaixiang Hao,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Xiaoying Shi,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Dong Liu,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Qinhui Song,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Ieuan Clay,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Gabriele Hintzen,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Jan Tchorz,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Laure C. Bouchez,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Gregory Michaud,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Peter Finan,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Vic E. Myer,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Tewis Bouwmeester,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Jeff Porter,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Marc Hild,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Fred Bassilana,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
• Christian N. Parker,

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Postfach, Basel, Switzerland

  ⨯
•  [ ... ],
• Feng Cong

  * E-mail: heinz.ruffner@novartis.com (HR); feng.cong@novartis.com (FC)

  Affiliation Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• [ view all ]
• [ view less ]